PTC three-lens brief
Evidence-based stock research on PTC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 15% of its 52-week range — deep in the lower band.
- Trading at 15% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 12.6pp over 30 days.
- P/E of 12.0 — trading at a value multiple.
- Analyst mean target $179.25 — 44% above current (20 analysts).
PTC closed at $124.88 (+0.88%) as of 2026-07-10. Market cap: $14.42B. P/E (trailing) 12.0. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 12.0 — trading at a value multiple.; analyst mean target $179.25 — 44% above current (20 analysts).. Concerns: trading at 15% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $774.30M, net income $590.72M, free cash flow $986.05M. Watching for: 2026-08-05 earnings release (25 days out).
Why three lenses on PTC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PTCacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PTC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PTC brief"></iframe>